Stock Analiz

Organon & Co. (OGN) stock forecast and price target

Price $13.90 · data as of November 13, 2026

12-month price target

Average target$10.33
Upside / downside−25.7%
Analysts3
ConsensusNone
Low $8.00Average $10.33High $14.00

Gold marker: average target · white marker: today’s price ($13.90)

Analyst ratings

Strong buy 0Buy 0Hold 3Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$3.44−6.1%$6.2B
Next fiscal year
ends December 31, 2027
$3.65+6.2%$6.3B
Next quarter
ends December 31, 2026
$0.95+50.2%$1.5B
Quarter after
ends March 31, 2027
$0.92+29.8%$1.5B

Consensus of the analysts covering Organon &, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Our model vs. Wall Street

Analysts see 25.7% downside over 12 months. Our discounted cash flow model with moderate assumptions puts Organon &’s intrinsic value about 93% above today’s market value, and it scores 2.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Organon & stock price target?

The average 12-month target from 3 analysts is $10.33, 25.7% below the current price of $13.90 Targets range from $8.00 to $14.00.

Is Organon & a buy according to analysts?

The consensus rating is “None” (3 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Organon & expected to earn?

Analysts expect EPS of $3.44 for the fiscal year ending December 31, 2026 and $3.65 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.